A Hypertension Risk Score for Middle-Aged and Older Adults by Kshirsagar, Abhijit V. et al.
A Hypertension Risk Score for Middle-Aged and Older Adults
Abhijit V. Kshirsagar, MD, MPH1, Ya-lin Chiu, MS2, Andrew S. Bomback, MD, MPH3, Phyllis
A. August, MD4, Anthony J. Viera, MD, MPH5, Romulo E. Colindres, MD, MPSH1, and
Heejung Bang, PhD2
1Department of Medicine, UNC Kidney Center and Division of Nephrology and Hypertension,
School of Medicine, Chapel Hill, NC
2Department of Public Health, Division of Biostatistics and Epidemiology, Weill Medical College of
Cornell University, New York, NY
3Division of Nephrology, Columbia University School of Medicine, New York, NY
4Department of Medicine, Division of Nephrology and Hypertension, Weill Medical College of
Cornell University, New York, NY
5Department of Family Medicine, UNC School of Medicine, Chapel Hill, NC
Abstract
Determining which demographic and medical variables predict the development of hypertension
could help clinicians stratify risk in both prehypertensive and nonhypertensive persons. Subject-
level data from 2 community-based biracial cohorts were combined to ascertain the relationship
between baseline characteristics and incident hypertension. Hypertension, defined as diastolic
blood pressure ≥90 mm Hg, systolic blood pressure ≥140 mm Hg, or reported use of medication
known to treat hypertension, was assessed prospectively at 3, 6, and 9 years. Internal validation
was performed by the split-sample method with a 2:1 ratio for training and testing samples,
respectively. A scoring algorithm was developed by converting the multivariable regression
coefficients to integer values. Age, level of systolic or diastolic blood pressure, smoking, family
history of hypertension, diabetes mellitus, high body mass index, female sex, and lack of exercise
were associated with the development of hypertension in the training sample. Regression models
showed moderate to high capabilities of discrimination between hypertension vs nonhypertension
(area under the receiver operating characteristic curve 0.75–0.78) in the testing sample at 3, 6, and
9 years of follow-up. This risk calculator may aide health care providers in guiding discussions
with patients about the risk for progression to hypertension.
The designation of prehypertension1,2 has two important goals.3 The first goal is to focus
attention on a segment of the population with higher-than-normal cardiovascular disease
risk.4-7 The second goal, often forgotten, is to identify individuals for whom targeted
approaches to prevent or delay the onset of hypertension might be valuable.
©2010 Wiley Periodicals, Inc.
Address for correspondence: Abhijit V. Kshirsagar, MD, MPH, Department of Medicine, UNC Kidney Center and Division of
Nephrology and Hypertension, School of Medicine, CB 7155 7017 Burnett-Womack Hall, Chapel Hill, NC 27599,
sagar@med.unc.edu.
Author contributions: Study concept and design: Kshirsagar, Bang, and Bomback; Analysis and Interpretation of data: Bang, Chiu,
Kshirsagar, and Bomback; Drafting of the manuscript: Kshirsagar, Bomback, and Bang; Critical revisions of manuscript and
important intellectual content: August, Colindres, and Viera; Statistical expertise: Bangand Chiu; Obtaining funding: none; Study
supervision: Kshirsagar and Bang.
NIH Public Access
Author Manuscript
J Clin Hypertens (Greenwich). Author manuscript; available in PMC 2013 June 17.
Published in final edited form as:













In the United States alone, 70 million adults are estimated to have blood pressure (BP)
within the broad range of prehypertension (systolic BP [SBP] from 120 to 139 mm Hg and/
or diastolic BP [DBP] from 80 to 89 mm Hg).8 These individuals have a variety of comorbid
medical conditions that may independently affect BP.7,9 Consequently, the risk of
progression to overt hypertension likely varies, and clinicians face the challenge of correctly
identifying individuals at high risk.
Determining which demographic and medical variables predict the development of
hypertension could help clinicians risk-stratify nonhypertensive individuals, including those
with prehypertension. Contemporary studies examining risk factors for progression may
have limited generalizability because of the reliance on a single cohort10-12 that lacks
minority representation and has relatively short follow-up periods.
We therefore developed a simple method to help clinicians determine future risk for
hypertension. We had two requirements for this model-based system: (1) the use of routinely
available and minimally intrusive demographic and medical variables that are easily
understood by lay persons and available to health care providers; and (2) the development of




We analyzed subject-level data from 2 community-based, prospective, public-use datasets to
ascertain the relationship between baseline characteristics and incident hypertension. Risk
prediction models were developed based on data available in nonhypertensive patients at
baseline.
Study Population
Data from 2 nonconcurrent cohort studies were combined: the Atherosclerosis Risk in
Communities (ARIC) study and the Cardiovascular Health Study (CHS) (https://
biolincc.nhlbi.nih.gov/home/). Detailed descriptions of these two studies have been
published previously.13,14
Briefly, ARIC enrolled 15,732 participants aged 45 to 64 years between 1987 and 1989
(visit 1) from 4 communities and followed them for a maximum of 4 visits, approximately 3
years apart, for a maximum follow-up of 9 years. CHS recruited 5201 participants 65 years
and older between 1989 and 1990 from 4 communities. Both studies recruited from 2
communities in common: Forsyth County, NC, and Washington County, MD. The two
distinct recruiting regions selected by ARIC are suburban Minneapolis, MN, and Jackson,
MS, whereas CHS recruited from Sacramento, CA, and Pittsburg, PA. Between 1992 and
1993, CHS enrolled an additional 687 black persons to increase minority participation. The
CHS participants were followed annually for up to 10 years.
The ARIC and CHS cohorts are felt to be highly complementary in many aspects: (1) both
were designed and conducted by the National Heart, Lung, and Blood Institute (NHLBI); (2)
age ranges of the study participants and the study periods are continuous but without
redundancy; (3) both studies enrolled black and white participants; and (4) data collection
procedures, measurement processes, and study protocols were highly consistent.
In this analysis, we assessed the development of hypertension status at 3, 6, and 9 years of
follow-up. Hypertension was defined as DBP ≥90 mm Hg or SBP ≥140 mm Hg or reporting
the use of medication known to treat hypertension.
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We chose our candidate covariates among the ones that were validated from the literature
and several new ones that are suspected of playing important roles in the development of
hypertension.15-29 As such, our covariate selection can be regarded as being guided by
scientific as well as numeric evidence. The following variables served as standard candidate
risk factors: age, sex, body mass index (BMI), waist circumference, exercise, diabetes, SBP,
DBP, alcohol intake, smoking, and family history of hypertension. Additionally, we
examined the predictability of various laboratory variables such as total, high-density
lipoprotein, and low-density lipoprotein cholesterol and creatinine, and nutritional or diet-
related variables such as the consumption of soft drinks and intake of sodium, total calories,
carbohydrates, and fat.
BMI was computed using body weight and height measured under standardized conditions
by trained and certified staff. Physical activity level was estimated by a “sport index,”30
incorporating frequency, duration, and intensity of reported sports activities, information on
leisure time activities, and sweating. Caloric intake was assessed through a semiquantitative
food frequency interview.31,32 All medications taken during the 2 weeks prior to each study
examination were recorded based on bottle labels if provided (otherwise by participant
report). Smoking status, educational level, alcohol consumption, and parental history of
hypertension were self-reported.
While missing data are minimal for most variables, this was not the case for family history
of hypertension, a variable that was not measured in the CHS. Imputation of family history
of hypertension was performed in the CHS cohort (detailed in the next subsection).
Statistical Analyses
We identified a set of risk factors that were associated with the outcome of interest using
continuous covariates (for maximal use of information and power) and then categorized the
continuous covariates using well-accepted cut-points whenever available or otherwise using
intuitive, user-friendly cut-points. As such, continuous variables were used to select
significant risk factors and categoric variables were used to develop a risk scoring algorithm.
Specifically, we categorized BP variables at baseline using a 5-mm Hg interval for SBP and
a 10-mm Hg interval for DBP. Since those are the strongest predictors of future
hypertension, the use of multiple categories would capture the risk gradient properly. For the
obesity measure, we used clinical guidelines (http://www.nhlbi.nih.gov/guidelines/obesity/).
Age was also categorized using 10-year intervals starting from 45. These variables were
used for the risk scoring algorithm.
The definitions of some variables in the two separate cohorts, ARIC and CHS, differed. For
example, exercise in ARIC was defined as a binary variable (yes vs no), while in CHS it was
defined as a 3-level exposure (low, moderate, and high). Thus, we dichotomized the variable
in CHS by “no” vs all others. Family history of hypertension, which was collected in ARIC
but not in CHS, was imputed using a statistical technique for missing data (by MI procedure
in SAS [SAS Institute, Cary, NC]).33 This method is regarded as a standard method for
handling partially missing data in statistics, and imputed data are created using the
information contained in the observed data (here in ARIC).
Baseline characteristics of study participants are summarized using mean and standard
deviation for continuous variables and percentage for categoric variables. We randomly split
the study cohort into training sample and testing sample using a 2:1 ratio for internal
validation.
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In the training sample, multiple logistic regression was used to identify independent risk
factors for hypertension events. In the regression modeling, the main effects of individual
risk factors and their interaction effects with age were tested. In order to generate a simple
risk scoring algorithm, we intentionally did not consider/test other interaction effects
because interaction effects can increase the complexity of the algorithm greatly without
resulting in sufficient improvements in numeric and/or clinical performance characteristics.
We employed backward elimination (deleting a covariate with the largest P value at a time)
until we reached a parsimonious model that includes a set of covariates with all P values <.
05 (a conventional P value threshold) in the “ever” model, in which the outcome was
defined as the ever occurrence of hypertension during 9-year follow-up. We fitted the
resulting parsimonious model with the final set of the risk factors for 3-, 6-, and 9-year
models, in which the outcome was defined as the occurrence of hypertension at 3-, 6-, and 9-
year follow-ups, respectively. We also fitted the same sets of models after categorizing the
continuous covariates.
The magnitude of association between a risk factor and the outcome, controlling for other
covariates, was assessed by odds ratios along with 95% confidence intervals; statistical
significance was assessed by P value. We adopted a discrimination statistic, the area under
the receiver operating characteristic curve (AUC) to quantify the capability to distinguish
the events vs no events of hypertension.34 We computed the AUCs in the training as well as
testing samples in order to understand the discrimination capability of the final model in
different samples and with continuous vs categoric variables.
For constructing a risk assessment algorithm, we created a weighted risk scoring algorithm
by rounding the odds ratios in the final model to the nearest integer while preserving
monotonicity from the “training” sample. The 3-, 6-, and 9-year risks for total scores were
estimated from the model (by averaging subject-specific predicted risks derived from the
final model) as well as empirically (by counting how many people developed hypertension
among those who had the same total score at base-line) from the “testing” sample.
Finally, we re-generated the risk scoring algorithm and the risk table from the combined
cohort (training + testing samples) and suggest that these to be used in practice. Rationales
are that: (1) the similar results were obtained and we judged that the difference observed is
not likely to have clinical relevance, and (2) we hoped to come up with the most accurate
scoring algorithm and risk estimates by using the maximal sample size/information in the
given dataset (ARIC/CHS), while waiting for true external validation to be conducted in the
future.
Statistical analysis was performed using SAS version 9.1 software (SAS Institute, Cary,
NC). Two-sided hypotheses and tests were adopted for all statistical inferences.
RESULTS
The study cohort consisted of 11,407 men and women after exclusion of individuals with
prevalent hypertension. The training cohort consisted of 7683 participants, while the testing
cohort consisted of 3724 participants (based on a 2:1 ratio for model development and
internal validation). After excluding the patients with missing covariate data, the actual
sample sizes used for analyses were 7610 for the training sample and 3692 for the testing
sample.
Several baseline characteristics of the cohort are presented in Table I. The average age of the
cohort was 56 years, while the average BP was 115 mm Hg (systolic) and 70 mm Hg
(diastolic). The majority of participants (6709, or 59%) had BP below the prehypertensive
range. Other demographic and medical characteristics are also available in Table II.
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Among all participants included in the analysis, 33% (3795 of 11,407) progressed to
hypertension during the study period. Of the prehypertensive patients, 52% (2450 of 4693)
developed hypertension by study end, while 20% (1342 of 6709) of participants without
baseline prehypertension developed incident hypertension.
Risk Factors Associated With Incident Hypertension
Risk factors associated with incident hypertension at 3, 6, and 9 years of follow-up are
presented in Table II. Several characteristics were associated with developing hypertension
throughout the study period—age, SBP, DBP, smoking, family history of hypertension,
presence of diabetes mellitus, BMI, and the age–DBP interaction. Statistical significance for
female sex, family history of diabetes, and exercise did not reach a conventional threshold
(ie, P≤.05) in some models but the directions of the association with the outcomes were
consistent.
Internal Validation Evaluation of the final models (using continuous or categoric variables)
in the testing sample revealed the regression coefficients to be highly similar to the ones
obtained from the training sample. There was some attenuation of the statistical significance
of some of the variables, primarily due to smaller sample size in the testing sample (results
not shown). The regression models showed moderate to high capabilities of discrimination
between hypertension vs nonhypertension (AUC 0.74–0.80) in the training sample (AUC
0.74–0.77) in the testing sample.
Variable categorization did not result in considerable loss in the discrimination capability,
further justifying the use of an integer-based scoring system (Table III). We calculated the
hypertension risks for each individual in the testing sample using a scoring algorithm
derived from the training sample. To illustrate, Figure 1 displays 9-year risk per total score
at baseline, where the estimated risk from the model and the empirically estimated risk were
presented together.
Risk Scoring Algorithm
After finalizing the model, we fitted the final model in the combined sample (ie, training +
testing) to derive the ultimate scoring algorithm. Figure 2 provides a risk assessment
questionnaire that consists of 9 questions—age, sex, smoking, exercise, family history of
hypertension, BMI, diabetes, SBP, and DBP. Based on the total score from this
questionnaire, an individual’s risk for developing incident hypertension can then be
estimated at 3, 6, and 9 years (Table IV). For example, a man aged 45 with optimal BP (SBP
<110 mm Hg and DBP <70 mm hg) and no other risk factors would have a 3% to 5% risk of
developing hypertension in the next 3 to 9 years. At the other extreme, an older
prehypertensive woman who has many of the listed risk factors (eg, obesity, smoking, and
lack of exercise) has >70% chance of developing hypertension in the future.
DISCUSSION
We have developed a scoring algorithm to stratify persons at risk for developing
hypertension. This prediction rule translates a parsimonious set of medical and demographic
characteristics into an average like-lihood of developing hypertension among middle-aged
and older adults with up to 9 years of follow-up. These characteristics are often present
together and cumulatively affect the risk of hypertension. Most of the characteristics (eg,
age, sex, BP level) are easily identified by both health care providers and the general public.
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We found that the strongest predictors of incident hypertension were: (1) baseline SBP in
the pre-hypertension range; (2) advanced age; and (3) obesity. The treatment of hypertension
in the elderly can be complicated, and there still remains uncertainty as to whether the BP
goals we set for young individuals pertain to older individuals.35,36 Based on the risk score
that integrates and quantifies comorbid conditions, it may be possible to individualize the
approach to elderly persons. For example, a 75-year-old who is nondiabetic, regularly
exercises, and has never smoked could be viewed (and managed) differently from a 75-year-
old with identical systolic and diastolic recordings but a history of tobacco abuse, inactivity,
and impaired glucose tolerance. With regards to the potential effect of obesity on
hypertension risk, this tool may help fuel discussions between obese patients and their
primary care providers about the need for dietary and exercise lifestyle modifications, and
could feasibly even provide the context for discussions about weight loss reduction
medication or surgery.
We were surprised to find that certain variables did not independently predict onset of
hypertension after multivariate adjustment, including cholesterol, kidney function, and
caloric intake. We would stress that these are still important covariates for assessment of
cardiovascular risk, but maybe not as necessary for development of hypertension. Rather,
this study finds evidence that the 8 identified risk factors capture the overall risk very well.
While clinicians still continue to provide standard recommendations to patients, including
healthy eating and cholesterol lowering, the 8 risk factors may offer an improved and more
targeted strategy to prevent hypertension.
Risk scores are practical tools to help identify individuals at an increased risk for adverse
health outcomes. Clinicians can use our scoring system to communicate expected risk with
patients and to facilitate discussions about possible preventive strategies. The algorithm may
also motivate individuals to engage lifestyle change to lower the risk of hypertension and to
bring this topic to their health care providers. It also has potential public health applications.
It can be posted on medical Web sites for the public to access or may be used in community
settings to identify individuals who may wish to be referred to health care providers. The
identification of high-risk individuals with this scoring system can also be used to optimize
the benefit and cost-effectiveness of targeted screenings. At the very least, the prediction
rule can be used in concert with other public health initiatives to increase the awareness of
hypertension and hypertension-associated diseases.
LIMITATIONS AND STRENGTHS
This study should be evaluated in the context of the following limitations. Given the
inherent variability of BP, some participants may have been mis-classified even after
following a standard protocol. Yet, we believe that this would likely have been
nondifferential misclassification bias and thus would move any point estimates toward the
null. Second, the BP measurements were office- and clinic-based, whereas recent evidence
suggests that 24-hour BP recordings may bear more weight on clinical outcomes. These
results must therefore be interpreted as solely predicting the risk for progression to clinic-
based hypertension and may not reflect 24-hour ambulatory hypertension. Third, it was
necessary to impute data on family history for participants in the CHS cohort. The validity
of imputation is contingent on the data being missing at random, given a set of available
information. Finally, we did not validate our model in an external or independent dataset.
External validation on various populations/cohorts will help clarify the potential
generalizability of the algorithm to larger populations. In the future, we plan to assess the
performance of the risk calculator in independent datasets and community screening efforts.
Kshirsagar et al. Page 6













Still, the study has some notable strengths. We used data from a large, community-based
sample drawn from multiple locations, and participants were followed for 9 years. Both the
demographic composition of our dataset and the extended follow-up period of this dataset
add to previous work10-12 performed primarily in the Framingham cohort. The Framingham
cohort lacks sufficient data on blacks, and the follow-up period was confined to 4 years. Our
sample included representative data from both blacks and whites, and the nearly decade-long
follow-up period in this data gives clinicians an idea about not only which patients will
likely progress to frank hypertension, but also when these patients will do so. In addition,
the complementary age of the participants of the two cohorts, ARIC and CHS, provides an
age range that mirrors the age range of most individuals who are at risk for developing
hypertension. The study, however, does not include young adults, who may be more
commonly affected by obesity, and its subsequent effect on the development of
hypertension.
In addition to the set of risk factors identified by the Framingham cohort, we found that
exercise/physical activity significantly contributes to our new model. This is an important
finding because exercise is a scientifically supported protective factor that often fails to
reach statistical significance due to various issues (eg, difficulty in quantifying,
measurement error/misclassification). Moreover, it is a highly modifiable and dynamic
behavioral/life-style factor; change in exercise patterns can modify the risk score/status, in
contrast to demographic and health history variables, which are not modifiable. We focused
on scientifically validated risk factors instead of identifying novel risk factors and
elucidating complicated relationships among the risk factors and/or the outcome (eg,
interaction or nonlinear relationship) in order to develop a user-friendly risk scoring
algorithm.
CONCLUSIONS
We have developed a tool for predicting progression to overt hypertension that relies on
readily available demographic and medical risk factors. The risk calculator may be most
judiciously applied to individuals with prehypertension to better delineate subsequent risk
for progression to hypertension. It may furthermore facilitate discussions on how to most
effectively modify this risk.37-40
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Nine-year risk of developing hypertension in testing sample (N=3692) based on risk score
derived from training sample. (Scores 17 or greater were combined due to small sample
sizes in the testing sample for reliable estimation of risk. Risk score derived from the
training sample can be found in Figure 2. Blue bars denote risk estimated from the model
and purple bars denote risk estimated by counting [the number of events divided by the total
number of individuals at risk at baseline]).
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Risk scoring algorithm. (The final algorithm was derived from the combined sample
[training + testing sample]).
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Table I




Age, y 56 (9.0)
Sex, % female 54
Race, % white 83
Education, % <high school 48
Systolic BP, mm Hg 115 (12.5)
Diastolic BP, mm Hg 70 (8.8)
Total cholesterol, mmol/L 5.4 (1.0)
LDL cholesterol, mmol/L 3.5 (1.0)
HDL cholesterol, mmol/L 1.4 (0.4)
Creatinine, μmol/L 88.4 (26.5)
BMI, kg2/cm 26 (4.6)
Current exercise, % 71
Current alcohol use, % 74
Diabetes mellitus, % 7
Current smoker, % 25
Former smoker, % 34
Parental history of hypertension,
a
 % 46
Abbbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SD, standard deviation.
a
Data was imputed for the Cardiovascular Health Study (CHS) cohort by a statistical technique using the information available in the
Atherosclerosis Risk in Communities (ARIC) cohort as this variable was not collected in the CHS.
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Table III
Discrimination Statistics in Training Sample (N=7610) and Testing (N=3692) Sample
Area Under the Receiver Operating Characteristic Curve
DATASET, COVARIATE 3 Years 6 Years 9 Years Ever
Training, continuous 0.739 0.755 0.800 0.782
Training, categorical 0.747 0.760 0.799 0.783
Testing, continuous 0.751 0.743 0.773 0.761
Testing, categorical 0.754 0.747 0.776 0.763
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